Related Experiment Video
Updated: Oct 21, 2026

Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens
Published on: May 23, 2014
Summary of the changes in the human female genital tract as a consequence of maternal diethylstilbestrol therapy
Abstract:
The current evidence associating maternal ingestion of diethylstilbestrol (DES) with the subsequent appearance of clear-cell adenocarcinoma of the genital tract has been presented. Thus far, these cancers are rare among exposed females. DES, dienestrol, and hexestrol, all nonsteroidal synthetic estrogens, have been implicated. The tumors have appeared primarily in exposed subjects over the age of 14 yr with the median ranging from 18 to 19 yr. Nonneoplastic abnormalities have been observed commonly in the exposed, including vaginal adenosis, cervical erosion (ectropion), and transverse vaginal and cervical ridges. The highest incidence of vaginal adenosis was noted among those whose mothers began DES in early pregnancy, and no cases were observed among those whose mothers began treatment after the 18th wk. Current evidence suggests that these alterations as well as the carcinomas are of mullerian origin.
Insights
Maternal ingestion of synthetic estrogens like diethylstilbestrol (DES) is linked to rare genital tract cancers in daughters. These cancers and related abnormalities, such as vaginal adenosis, typically appear after age 14.
Area of Science:
- Gynecologic Oncology
- Endocrinology
- Reproductive Health
Background:
- Diethylstilbestrol (DES) is a synthetic estrogen previously prescribed to pregnant women.
- Concerns exist regarding the long-term health effects of in utero DES exposure.
- Clear-cell adenocarcinoma (CCA) is a rare cancer observed in DES-exposed individuals.
Purpose of the Study:
- To review the evidence linking maternal DES ingestion to genital tract cancers in offspring.
- To characterize the types of nonneoplastic abnormalities associated with DES exposure.
- To determine the age of onset and origin of DES-related malignancies.
Main Methods:
- Review of existing epidemiological and clinical evidence.
- Analysis of cancer incidence and age of onset in DES-exposed populations.
- Histopathological evaluation of associated nonneoplastic lesions.
Main Results:
- DES and related synthetic estrogens are implicated in rare genital tract cancers.
- Tumors primarily affect exposed females over 14 years old, with a median age of 18-19.
- Nonneoplastic findings include vaginal adenosis, cervical ectropion, and transverse ridges, with adenosis linked to early pregnancy exposure.
Conclusions:
- DES exposure in utero is associated with an increased risk of clear-cell adenocarcinoma.
- Both neoplastic and nonneoplastic changes are believed to originate from müllerian epithelium.
- Early pregnancy exposure appears to correlate with a higher incidence of vaginal adenosis.
Related Concept Videos
Oogenesis
Disorders of the Female Reproductive System
Development of Human Microbiota
Microbiota of the Urogenital Tract
Trichomoniasis

